For the year ending 2025-12-31, RS had -$101,500K decrease in cash & cash equivalents over the period. $502,500K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net sales | 14,294,300 |
| Cost of sales (exclusive of depreciation and amortization shown below) | 10,186,800 |
| Compensation expense | 1,709,500 |
| Other segment items | 1,085,000 |
| Depreciation and amortization expense | 278,200 |
| Impairment | 9,900 |
| Interest expense | 55,700 |
| Income tax provision | 227,600 |
| Net income | 741,600 |
| Depreciation and amortization expense | 278,200 |
| Impairment | 9,900 |
| Provision for credit losses | 3,000 |
| Deferred income tax provision | 37,100 |
| Stock-based compensation expense | 55,600 |
| Other | 12,700 |
| Accounts receivable | 195,400 |
| Inventories | 154,800 |
| Prepaid expenses and other assets | -75,800 |
| Accounts payable and other liabilities | -6,900 |
| Net cash provided by operating activities | 831,400 |
| Acquisitions, net of cash acquired | 2,800 |
| Purchases of property, plant and equipment | 328,900 |
| Proceeds from sales of property, plant and equipment | 17,200 |
| Other | 7,300 |
| Net cash used in investing activities | -321,800 |
| Proceeds from long-term debt borrowings | 2,701,000 |
| Principal payments on long-term debt | 2,424,300 |
| Cash dividends and dividend equivalents | 254,700 |
| Share repurchases | 594,100 |
| Taxes paid related to net share settlement of restricted stock units | 17,900 |
| Excise tax on repurchase of common shares | 10,000 |
| Other | -20,200 |
| Net cash used in financing activities | -620,200 |
| Effect of exchange rate changes on cash and cash equivalents | 9,100 |
| Decrease in cash and cash equivalents | -101,500 |
| Cash and cash equivalents, beginning balance | 318,100 |
| Cash and cash equivalents, ending balance | 216,600 |
RELIANCE, INC. (RS)
RELIANCE, INC. (RS)